MAD1L1 and rhabdomyosarcoma: Tumor predisposition has been observed in patients with biallelic LoF of BUB1B, TRIP13, and MAD1L1, with resulting elevated risks for rhabdomyosarcoma, Wilms tumor, and a variety of malignancies, respectively (7, 8, 27).